{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T23:43:37Z","timestamp":1785195817608,"version":"3.55.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","award":["406436\/2022-3"],"award-info":[{"award-number":["406436\/2022-3"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ejpb.2025.114638","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T11:30:19Z","timestamp":1737199819000},"page":"114638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Advances in soft nanoparticle-based platforms for human and veterinary trichomoniasis therapy: A scoping review"],"prefix":"10.1016","volume":"208","author":[{"given":"Raul Edison Luna","family":"Lazo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Miguel Stelmach","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Luiz","family":"Domingos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre de Fatima","family":"Cobre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Vitor","family":"Farago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiana","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Pontarolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9951-587X","authenticated-orcid":false,"given":"Luana Mota","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2025.114638_b0005","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.18.228486","article-title":"Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016","volume":"97","author":"Rowley","year":"2019","journal-title":"Bull World Health Organ."},{"key":"10.1016\/j.ejpb.2025.114638_b0010","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/OLQ.0000000000001355","article-title":"Sexually Transmitted Infections Among US Women and Men: Prevalence and Incidence Estimates, 2018","volume":"48","author":"Kreisel","year":"2021","journal-title":"Sex Transm Dis."},{"key":"10.1016\/j.ejpb.2025.114638_b0015","doi-asserted-by":"crossref","first-page":"E93","DOI":"10.1097\/OLQ.0000000000001013","article-title":"Prevalence of Trichomonas vaginalis Among Civilian, Noninstitutionalized Male and Female Population Aged 14 to 59 Years: United States, 2013 to 2016","volume":"46","author":"Flagg","year":"2019","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ejpb.2025.114638_b0020","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s11908-011-0213-9","article-title":"Refractory Trichomoniasis in HIV-positive and HIV-negative Subjects","volume":"13","author":"Miller","year":"2011","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ejpb.2025.114638_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually Transmitted Infections Treatment Guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ejpb.2025.114638_b0030","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.sxmr.2021.12.004","article-title":"Secnidazole for Trichomoniasis in Women and Men","volume":"10","author":"Muzny","year":"2022","journal-title":"Sex Med Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0035","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-020-04148-5","article-title":"Proteomic signatures of metronidazole-resistant Trichomonas vaginalis reveal novel proteins associated with drug resistance","volume":"13","author":"Lin","year":"2020","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ejpb.2025.114638_b0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4269\/ajtmh.13-0723","article-title":"Neglected Parasitic Infections in the United States: Trichomoniasis","volume":"90","author":"Secor","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ejpb.2025.114638_b0045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.OLQ.0000086609.95617.8D","article-title":"Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity?","volume":"30","author":"Magnus","year":"2003","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.ejpb.2025.114638_b0050","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1136\/sextrans-2012-051005","article-title":"Trichomoniasis and HIV interactions: a review","volume":"89","author":"Kissinger","year":"2013","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ejpb.2025.114638_b0055","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00912-22","article-title":"In Vitro Effect of 5-Nitroimidazole Drugs against Trichomonas vaginalis Clinical Isolates","volume":"10","author":"Mtshali","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.ejpb.2025.114638_b0060","doi-asserted-by":"crossref","first-page":"175","DOI":"10.4103\/0975-7406.99013","article-title":"Locust bean gum: Exploring its potential for biopharmaceutical applications","volume":"4","author":"Dion\u00edsio","year":"2012","journal-title":"J Pharm Bioallied Sci"},{"key":"10.1016\/j.ejpb.2025.114638_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jconrel.2017.12.004","article-title":"Polymeric gels for intravaginal drug delivery","volume":"270","author":"Cook","year":"2018","journal-title":"J Control Release"},{"key":"10.1016\/j.ejpb.2025.114638_b0070","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19061549","article-title":"Approaches in Polymeric Nanoparticles for Vaginal Drug Delivery: A Review of the State of the Art","volume":"19","author":"Leyva-G\u00f3mez","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ejpb.2025.114638_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects","volume":"16","author":"Patra","year":"2018","journal-title":"Journal of Nanobiotechnology"},{"key":"10.1016\/j.ejpb.2025.114638_b0080","doi-asserted-by":"crossref","first-page":"7686","DOI":"10.1002\/anie.200501321","article-title":"Soft nanotechnology with soft nanoparticles","volume":"44","author":"Nayak","year":"2005","journal-title":"Angew Chem Int Ed Engl"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114638_b0085","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3390\/pharmaceutics15030874","article-title":"Status and future scope of soft nanoparticles-based hydrogel in wound healing","volume":"15","author":"Sari","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114638_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.indcrop.2023.117602","article-title":"Herbal drugs-loaded soft nanoparticles for treating skin disorders: Where do we stand?","volume":"206","author":"Reolon","year":"2023","journal-title":"Ind Crops Prod"},{"key":"10.1016\/j.ejpb.2025.114638_b0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int J Evid Based Healthc"},{"key":"10.1016\/j.ejpb.2025.114638_b0100","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejpb.2025.114638_b0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0110","doi-asserted-by":"crossref","first-page":"e1125","DOI":"10.1002\/cl2.1125","article-title":"Guidance for producing a Campbell evidence and gap map","volume":"16","author":"White","year":"2020","journal-title":"Campbell Syst. Rev."},{"key":"10.1016\/j.ejpb.2025.114638_b0115","first-page":"1","article-title":"Mapping reviews, scoping reviews, and evidence and gap maps (EGMs): the same but different\u2014 the \u201cBig Picture\u201d review family","volume":"12","author":"Campbell","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0120","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"2021","author":"Page","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.ejpb.2025.114638_b0125","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.ejpb.2023.01.007","article-title":"In situ gelling drug delivery systems for topical drug delivery","volume":"184","author":"Kolawole","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2025.114638_b0130","article-title":"Engineering drug delivery systems to overcome the vaginal mucosal barrier: Current understanding and research agenda of mucoadhesive formulations of vaginal delivery","volume":"70","author":"Valamla","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ejpb.2025.114638_b0135","article-title":"Thiolated polymers: An overview of mucoadhesive properties and their potential in drug delivery via mucosal tissues","volume":"85","author":"Mfoafo","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ejpb.2025.114638_b0140","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/pharmaceutics13020198","article-title":"Polymer\u2013Lipid Pharmaceutical Nanocarriers: Innovations by New Formulations and Production Technologies","volume":"13","author":"Bochicchio","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114638_b0145","article-title":"Advances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery","volume":"29","author":"Liu","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2025.114638_b0150","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/acs.molpharmaceut.1c00928","article-title":"Polymersomes: Soft Nanoparticles from Miktoarm Stars for Applications in Drug Delivery","volume":"19","author":"Baghbanbashi","year":"2022","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejpb.2025.114638_b0155","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201900506","article-title":"Soft\u2010Nanoparticle Functionalization of Natural Hydrogels for Tissue Engineering Applications","volume":"8","author":"Elkhoury","year":"2019","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.ejpb.2025.114638_b0160","article-title":"Current status and evidence gap map of betamethasone-loaded nanostructured formulations as cutaneous delivery systems: A scoping review","volume":"101","author":"da Gra\u00e7a Toledo","year":"2024","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.ejpb.2025.114638_b0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2015.05.005","article-title":"Cutaneous penetration of soft nanoparticles via photodamaged skin: Lipid-based and polymer-based nanocarriers for drug delivery","volume":"94","author":"Hung","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"6","key":"10.1016\/j.ejpb.2025.114638_b0170","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s44222-023-00040-w","article-title":"Delivery technologies for women\u2019s health applications","volume":"1","author":"Swingle","year":"2023","journal-title":"Nature Reviews Bioengineering"},{"key":"10.1016\/j.ejpb.2025.114638_b0175","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.addr.2014.12.004","article-title":"Polymer-based nanocarriers for vaginal drug delivery","volume":"92","author":"das Neves","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122799","article-title":"Thermoresponsive mucoadhesive hybrid gels in advanced drug delivery systems","volume":"636","author":"Mfoafo","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2025.114638_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2023.111868","article-title":"Polymer-based biomaterials for pharmaceutical and biomedical applications: A focus on topical drug administration","volume":"187","author":"Pires","year":"2023","journal-title":"Eur Polym J"},{"key":"10.1016\/j.ejpb.2025.114638_b0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0168-3659(01)00520-X","article-title":"Development and in vitro evaluation of a mucoadhesive vaginal delivery system for progesterone","volume":"77","author":"Valenta","year":"2001","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114638_b0195","doi-asserted-by":"crossref","DOI":"10.1021\/acs.molpharmaceut.4c00199","article-title":"Single-Step Extrusion Process for Formulation Development of Self-Emulsifying Granules for Oral Delivery of a BCS Class IV Drug","author":"Kulkarni","year":"2024","journal-title":"Mol Pharm"},{"key":"10.1016\/j.ejpb.2025.114638_b0200","first-page":"191","article-title":"Lipid nanoparticles: A challenging approach for oral delivery of BCS Class-II drugs, Futur","volume":"4","author":"Poovi","year":"2018","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejpb.2025.114638_b0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2017.07.001","article-title":"Beyond liposomes: Recent advances on lipid based nanostructures for poorly soluble\/poorly permeable drug delivery","volume":"68","author":"Teixeira","year":"2017","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.ejpb.2025.114638_b0210","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jconrel.2017.01.014","article-title":"BCS class IV drugs: Highly notorious candidates for formulation development","volume":"248","author":"Ghadi","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2025.114638_b0215","first-page":"471","article-title":"Current approaches in lipid-based nanocarriers for oral drug delivery, Drug Deliv","volume":"11","author":"Plaza-Oliver","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.ejpb.2025.114638_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115136","article-title":"Lipid nanoparticles for targeted delivery of anticancer therapeutics: Recent advances in development of siRNA and lipoprotein-mimicking nanocarriers","volume":"203","author":"Yaghmur","year":"2023","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0225","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.2174\/1381612825666190709210703","article-title":"Nanomedicines to Treat Skin Pathologies with Natural Molecules","volume":"25","author":"Esposito","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejpb.2025.114638_b0230","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s12639-017-0930-6","article-title":"Anti-Trichomonas vaginalis activity of nano Micana cordifolia and Metronidazole: an in vitro study","volume":"41","author":"Vazini","year":"2017","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.ejpb.2025.114638_b0235","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.biopha.2016.12.099","article-title":"A brief review on the application of nanoparticle enclosed herbal medicine for the treatment of infective endocarditis","volume":"87","author":"Namdari","year":"2017","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejpb.2025.114638_b0240","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cegh.2020.04.028","article-title":"The uses of gold nanoparticles and Citrullus colocynthis L. nanoparticles against Giardia lamblia in vivo","volume":"8","author":"Al-Ardi","year":"2020","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.ejpb.2025.114638_b0245","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.partic.2021.05.009","article-title":"Nanoemulsions for drug delivery","volume":"64","author":"Wilson","year":"2022","journal-title":"Particuology"},{"key":"10.1016\/j.ejpb.2025.114638_b0250","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6640103","article-title":"Nanoemulsion: An Emerging Novel Technology for Improving the Bioavailability of Drugs","author":"Preeti","year":"2023","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.ejpb.2025.114638_b0255","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s12639-021-01371-4","article-title":"Anti-parasitic activity of nano Citrullus colocynthis and nano Capparis spinose against Trichomonas vaginalis in vitro","volume":"45","author":"Al-Ardi","year":"2021","journal-title":"J. Parasit. Dis."},{"key":"10.1016\/j.ejpb.2025.114638_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113865","article-title":"Women-specific routes of administration for drugs: A critical overview","volume":"176","author":"das Neves","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128701","article-title":"Xanthan-carrageenan film containing sesame seed oil: A nanocomposite pharmaceutical platform for trichomoniasis treatment","volume":"257","author":"Saccol","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114638_b0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/venereology1010005","article-title":"Novel treatment approaches to combat trichomoniasis, a neglected and sexually transmitted infection caused by Trichomonas vaginalis: Translational perspectives","volume":"1","author":"Rigo","year":"2022","journal-title":"Venereology"},{"key":"10.1016\/j.ejpb.2025.114638_b0275","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/jps.23577","article-title":"Vaginal films for drug delivery","volume":"102","author":"Machado","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.ejpb.2025.114638_b0280","first-page":"2907","article-title":"A novel nanotechnological mucoadhesive and fast-dissolving film for vaginal delivery of clotrimazole: design, characterization, and in vitro antifungal action, Drug Deliv","volume":"12","author":"Cervi","year":"2022","journal-title":"Transl Res"},{"key":"10.1016\/j.ejpb.2025.114638_b0285","article-title":"A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives","volume":"27","author":"Liu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2025.114638_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.106156","article-title":"Nanoliposomes increases Anti-Trichomonas vaginalis and apoptotic activities of metronidazole","volume":"224","author":"Ebrahimi","year":"2021","journal-title":"Acta Trop"},{"key":"10.1016\/j.ejpb.2025.114638_b0295","first-page":"168","article-title":"Plants_used_to_treat_tabereba_malaria_like_fever_in_Iranian_traditional_medicine","volume":"1","author":"Ghafari","year":"2013","journal-title":"International Journal of Traditional and Natural Medicines"},{"key":"10.1016\/j.ejpb.2025.114638_b0300","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.lwt.2012.03.027","article-title":"Antioxidant and antimicrobial properties of essential oils encapsulated in zein nanoparticles prepared by liquid\u2013liquid dispersion method","volume":"48","author":"Wu","year":"2012","journal-title":"LWT Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114638_b0305","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jmii.2022.06.006","article-title":"Green synthesis of nano-liposomes containing Bunium persicum and Trachyspermum ammi essential oils against Trichomonas vaginalis","volume":"56","author":"Siyadatpanah","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ejpb.2025.114638_b0310","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.colsurfb.2017.04.058","article-title":"Endocytosis and intracellular traffic of cholesterol-PDMAEMA liposome complexes in human epithelial-like cells","volume":"156","author":"Szymanowski","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ejpb.2025.114638_b0315","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/j.lwt.2011.03.003","article-title":"Nanoencapsulation of essential oils to enhance their antimicrobial activity in foods","volume":"44","author":"Dons\u00ec","year":"2011","journal-title":"LWT Food Sci. Technol."},{"key":"10.1016\/j.ejpb.2025.114638_b0320","first-page":"10","article-title":"Pure Thymol, and its Nanoliposome and Nanoparticle Forms, Inhibit Trichomonas vaginalis Infection in Culture, Iranian","volume":"17","author":"Jalili","year":"2023","journal-title":"Journal of Toxicology"},{"key":"10.1016\/j.ejpb.2025.114638_b0325","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000086666","article-title":"Liposomes and Niosomes as Topical Drug Delivery Systems","volume":"18","author":"Choi","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.ejpb.2025.114638_b0330","doi-asserted-by":"crossref","first-page":"374","DOI":"10.4103\/0110-5558.76435","article-title":"Niosome: A future of targeted drug delivery systems","volume":"1","author":"Karim","year":"2010","journal-title":"J Adv Pharm Technol Res"},{"key":"10.1016\/j.ejpb.2025.114638_b0335","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/9781119247159.ch10","article-title":"Liposomes and niosomes","author":"Wen","year":"2018","journal-title":"Emulsion-Based Systems for Delivery of Food Active Compounds: Formation, Application, Health and Safety"},{"key":"10.1016\/j.ejpb.2025.114638_b0340","first-page":"263","article-title":"Promising potent in vitro activity of curcumin and quercetin nano-niosomes against Trichomonas vaginalis","volume":"68","author":"Hezarjaribi","year":"2022","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.ejpb.2025.114638_b0345","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","article-title":"Pharmaceutical Nanotechnology Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-Huertas","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2025.114638_b0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105379","article-title":"Gellan gum-based hydrogel containing nanocapsules for vaginal indole-3-carbinol delivery in trichomoniasis treatment","volume":"151","author":"Osmari","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2025.114638_b0355","article-title":"The use of natural gums to produce nano-based hydrogels and films for topical application","volume":"626","author":"Sari","year":"2022","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2025.114638_b0360","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1021\/cr030441b","article-title":"Chitosan chemistry and pharmaceutical perspectives","volume":"104","author":"Kumar","year":"2004","journal-title":"Chem Rev"},{"key":"10.1016\/j.ejpb.2025.114638_b0365","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.carbpol.2016.05.028","article-title":"A review on chitosan-cellulose blends and nanocellulose reinforced chitosan biocomposites: Properties and their applications","volume":"150","author":"Abdul Khalil","year":"2016","journal-title":"Carbohydr Polym"},{"key":"10.1016\/j.ejpb.2025.114638_b0370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s12221-017-6690-1","article-title":"Antimicrobial properties of chitosan nanoparticles: Mode of action and factors affecting activity","volume":"18","author":"Divya","year":"2017","journal-title":"Fibers Polym."},{"key":"10.1016\/j.ejpb.2025.114638_b0375","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s11095-014-1528-7","article-title":"Drug-free chitosan coated poly(isobutylcyanoacrylate) nanoparticles are active against Trichomonas vaginalis and non-toxic towards pig vaginal mucosa","volume":"32","author":"Pradines","year":"2015","journal-title":"Pharm Res"},{"issue":"3","key":"10.1016\/j.ejpb.2025.114638_b0380","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0014-4894(86)90049-4","article-title":"Tritrichomonas foetus: ultrastructure and cytochemistry of endocytosis","volume":"62","author":"Benchimol","year":"1986","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ejpb.2025.114638_b0385","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ijpharm.2018.07.006","article-title":"Surface-dependent endocytosis of poly(isobutylcyanoacrylate) nanoparticles by Trichomonas vaginalis","volume":"548","author":"Malli","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.ejpb.2025.114638_b0390","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11686-020-00255-6","article-title":"In Vitro Antiprotozoal Effects of Nano-chitosan on Plasmodium falciparum, Giardia lamblia and Trichomonas vaginalis","volume":"66","author":"Elmi","year":"2021","journal-title":"Acta Parasitol"},{"key":"10.1016\/j.ejpb.2025.114638_b0395","article-title":"Composite Thermoresponsive Hydrogel with Auranofin-Loaded Nanoparticles for Topical Treatment of Vaginal Trichomonad Infection","volume":"2","author":"Zhang","year":"2019","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.ejpb.2025.114638_b0400","first-page":"4015","article-title":"Metronidazole-loaded nanoparticulate thermoreversible gel for gynecologic infection of Trichomonas vaginalis","volume":"14","author":"Fang","year":"2022","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ejpb.2025.114638_b0405","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.3390\/pharmaceutics14102112","article-title":"Locust Bean Gum Nano-Based Hydrogel for Vaginal Delivery of Diphenyl Diselenide in the Treatment of Trichomoniasis: Formulation Characterization and In Vitro Biological Evaluation","volume":"14","author":"dos Reis","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114638_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.106011","article-title":"Mucoadhesive gellan gum hydrogel containing diphenyl diselenide-loaded nanocapsules presents improved anti-candida action in a mouse model of vulvovaginal candidiasis","volume":"167","author":"Zimmermann","year":"2021","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.ejpb.2025.114638_b0415","doi-asserted-by":"crossref","first-page":"319","DOI":"10.15517\/rev.biol.trop..v70i1.48746","article-title":"Amoebicidal and trichomonicidal capacity of polymeric nanoparticles loaded with extracts of the plants Curcuma longa (Zingiberaceae) and Berberis vulgaris (Berberidaceae)","volume":"70","author":"Pacheco-Ordaz","year":"2022","journal-title":"Rev Biol Trop"},{"key":"10.1016\/j.ejpb.2025.114638_b0420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/tropicalmed4020088","article-title":"The One Health Approach\u2014Why Is It So Important?","volume":"4","author":"Mackenzie","year":"2019","journal-title":"Tropical Medicine and Infectious Disease"},{"key":"10.1016\/j.ejpb.2025.114638_b0425","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.meegid.2007.01.002","article-title":"Molecular identity and heterogeneity of Trichomonad parasites in a closed avian population","volume":"7","author":"Gaspar da Silva","year":"2007","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ejpb.2025.114638_b0430","first-page":"151","article-title":"Antitrichomonal activity of nanoemulsion of carvacrol on Trichomonas galline: formulation development and in vitro characterization","volume":"68","author":"Yazdani","year":"2022","journal-title":"Ann Parasitol"},{"key":"10.1016\/j.ejpb.2025.114638_b0435","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2885.1992.tb01032.x","article-title":"In vitro nitroimidazole resistance of Trichomonas gallinae and successful therapy with an increased dosage of ronidazole in racing pigeons (Columba livia domestica)","volume":"15","author":"Franssen","year":"1992","journal-title":"J Vet Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.ejpb.2025.114638_b0440","first-page":"32","article-title":"In vitro and in vivo activity of the essential oil and nanoemulsion of Cymbopogon flexuosus against Trichomonas gallinae","volume":"11","author":"Baccega","year":"2021","journal-title":"Avicenna J Phytomed"},{"key":"10.1016\/j.ejpb.2025.114638_b0445","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1007\/s00436-021-07263-z","article-title":"Antitrichomonal activity of metronidazole-loaded lactoferrin nanoparticles in pigeon trichomoniasis","volume":"120","author":"Tabari","year":"2021","journal-title":"Parasitol Res"},{"key":"10.1016\/j.ejpb.2025.114638_b0450","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actatropica.2015.02.002","article-title":"Combinations of ascaridole, carvacrol, and caryophyllene oxide against Leishmania","volume":"145","author":"Pastor","year":"2015","journal-title":"Acta Trop"},{"issue":"11","key":"10.1016\/j.ejpb.2025.114638_b0455","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/molecules24112072","article-title":"In vitro and in vivo effectiveness of carvacrol, thymol and linalool against Leishmania infantum","volume":"24","author":"Youssefi","year":"2019","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.ejpb.2025.114638_b0460","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/pharmaceutics12070604","article-title":"Protein-based nanoparticles as drug delivery systems","volume":"12","author":"Hong","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2025.114638_b0465","first-page":"67","article-title":"Effect of Polymer-Based Nanoparticles on the Assay of Antimicrobial Drug Delivery Systems, Multifunctional Systems for Combined Delivery","author":"Gumustas","year":"2017","journal-title":"Biosensing and Diagnostics"},{"key":"10.1016\/j.ejpb.2025.114638_b0470","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cvfa.2005.03.002","article-title":"Venereal diseases of cattle: Natural history, diagnosis, and the role of vaccines in their control","volume":"21","author":"BonDurant","year":"2005","journal-title":"Veterinary Clinics of North America - Food Animal Practice"},{"key":"10.1016\/j.ejpb.2025.114638_b0475","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2460\/javma.1999.214.07.1051","article-title":"Prevalence of tritrichomonas fetus in a bull population and effect on production in a large cow-calf enterprise","volume":"214","author":"Rae","year":"1999","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.ejpb.2025.114638_b0480","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.biopha.2017.09.007","article-title":"Diamine derivative anti-Trichomonas vaginalis and anti-Tritrichomonas foetus activities by effect on polyamine metabolism","volume":"95","author":"Rigo","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejpb.2025.114638_b0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/jmm.0.047365-0","article-title":"Diagnosis of tritrichomonas foetus-infected bulls, an ultimate approach to eradicate bovine trichomoniasis in US cattle?","volume":"62","author":"Yao","year":"2013","journal-title":"J Med Microbiol"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641125000141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:39:42Z","timestamp":1762331982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641125000141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":97,"alternative-id":["S0939641125000141"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114638","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in soft nanoparticle-based platforms for human and veterinary trichomoniasis therapy: A scoping review","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2025.114638","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114638"}}